The CRISPR Gene Editing market is a subset of the larger Genomics market. It is a rapidly growing field, driven by advances in gene editing technology and the potential for its applications in a variety of areas. CRISPR technology enables scientists to make precise changes to the genetic code of living organisms, allowing them to modify or delete genes, and even insert new ones. This technology has the potential to revolutionize the way we treat diseases, create new crops, and even modify the human genome.
The CRISPR Gene Editing market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and Horizon Discovery. Show Less Read more
